Cancer cells change their glucose metabolism to overcome increased ROS: One step from cancer cell to cancer stem cell?

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Zahra Ghanbari MovahedKamran Mansouri

Abstract

Cancer cells can adapt to low energy sources in the face of ATP depletion as well as to their high levels of ROS by altering their metabolism and energy production networks which might also have a role in determining cell fate and developing drug resistance. Cancer cells are generally characterized by increased glycolysis. This is while; cancer stem cells (CSCs) exhibit an enhanced pentose phosphate pathway (PPP) metabolism. Based on the current literature, we suggest that cancer cells when encountering ROS, first increase the glycolysis rate and then following the continuation of oxidative stress, the metabolic balance is skewed from glycolysis to PPP. Therefore, we hypothesize in this review that in cancer cells this metabolic deviation during persistent oxidative stress might be a sign of cancer cells' shift towards CSCs, an issue that might be pivotal in more effective targeting of cancer cells and CSCs.

References

Sep 30, 1991·The American Journal of Medicine·C G Cochrane
Jul 17, 1995·Biochemical and Biophysical Research Communications·G L WangG L Semenza
Jan 20, 1995·The Journal of Biological Chemistry·G L Wang, G L Semenza
Jan 1, 1994·International Journal of Radiation Biology·P A Riley
Aug 1, 1994·The American Journal of Physiology·M F AllardG D Lopaschuk
Jan 1, 1995·Annual Review of Nutrition·K D Wilkinson
Jun 28, 1996·The Journal of Biological Chemistry·T GruneK J Davies
Aug 26, 1998·The Journal of Biological Chemistry·C GodonJ Labarre
Oct 31, 1998·The Biochemical Journal·T ReinheckelT Grune
Oct 31, 1998·Current Opinion in Genetics & Development·G L Semenza
May 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·O UllrichK J Davies
Jun 23, 2000·Annals of the New York Academy of Sciences·D R SpitzY J Lee
Feb 13, 2001·Trends in Biochemical Sciences·D A OkarA J Lange
Nov 2, 2001·Nature·T ReyaI L Weissman
Jan 5, 2002·Physiological Reviews·Wulf Dröge
Oct 29, 2002·The Journal of Biological Chemistry·Reshma ShringarpureKelvin J A Davies
Feb 24, 1956·Science·O WARBURG
Aug 10, 1956·Science·S WEINHOUSE
Oct 8, 2003·Current Medicinal Chemistry·Masayasu InoueKozo Utsumi
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Theresa L WellmanKaren M Lounsbury
Mar 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Qing LiuThomas Kietzmann
Nov 25, 2004·The Journal of Biological Chemistry·Iman M AhmadDouglas R Spitz
Jan 22, 2005·Critical Reviews in Oncology/hematology·Christiane Brahimi-Horn, Jacques Pouysségur
Aug 2, 2005·Cell Metabolism·Joslyn K BrunelleNavdeep S Chandel
Sep 6, 2005·Free Radical Biology & Medicine·Melvin CallapinaBernhard Brüne

❮ Previous
Next ❯

Citations

Jan 25, 2020·International Journal of Radiation Biology·Mohsen SisakhtZahra Khoshdel
Apr 25, 2020·Frontiers in Oncology·Rikki A M BrownPeter J Leedman
Aug 31, 2019·Oxidative Medicine and Cellular Longevity·Anastasiya V SnezhkinaAlexey A Dmitriev
Sep 26, 2020·Frontiers in Oncology·Carlos A Gonzalez-VillarrealElsa N Garza-Treviño
Sep 29, 2020·Frontiers in Oncology·Asunción Espinosa-SánchezAmancio Carnero
May 16, 2020·International Journal of Molecular Sciences·Vikas Bhardwaj, Jun He
Oct 9, 2020·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Pegah FarhadiKamran Mansouri
Dec 3, 2020·Genes & Development·Minhong Shen, Yibin Kang
Dec 15, 2020·World Journal of Stem Cells·Xu Gao, Qiong-Zhu Dong
Oct 25, 2020·Biochemical and Biophysical Research Communications·Na Hui KimSin-Aye Park
Nov 20, 2020·Experimental Cell Research·Kristopher MontroseJuha Saarikangas
Jun 18, 2021·Cancer Cell International·Kosuke YoshidaHiroaki Kajiyama
Jun 15, 2021·Frontiers in Immunology·Khalil KhalafMariusz Kaczmarek
Aug 8, 2021·International Journal of Molecular Sciences·Michael G AppiahMotomu Shimaoka
Aug 3, 2021·American Journal of Hematology·Zizhen ChenYuan Zhou
Aug 3, 2021·The Journal of Nutritional Biochemistry·Maite Garcia-GuaschRaquel Moral

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.